Recruiting A Study of CC312 for Relapsed/Refractory Autoimmune Diseases NCT07193810 Conditions Autoimmune Diseases, Connective Tissue Diseases, IIM- Idiopathic Inflammatory Myopathies, +5 more Locations Deyang People's Hospital — Deyang, Sichuan, China View Trial Details
Recruiting Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD NCT07491523 Conditions SSc-Systemic Sclerosis Locations University of patras — Pátrai, Greece View Trial Details
Recruiting Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC NCT07355972 Conditions SSc-Systemic Sclerosis Locations Wuhan Union Hospita — Wuhan, Hubei, China View Trial Details
Recruiting CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087 Conditions ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +15 more Locations Institute of Hematology & Blood Diseases Hospital — Tianjin, China View Trial Details
Not Yet Recruiting RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases NCT07674147 Conditions Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +18 more Locations Nanjing Children's Hospital — Nanjing, Jiangsu, China Children's Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang, China View Trial Details
